Orally deliverable and anti-toxin antibodies and methods for making and using them

Details for Australian Patent Application No. 2005321974 (hide)

Owner Progenics Pharmaceuticals (Nevada), Inc.

Inventors Hansen, Genevieve; Demarest, Stephen J.

Agent Pizzeys

Pub. Number AU-B-2005321974

PCT Pub. Number WO2006/071877

Priority 60/639,827 27.12.04 US

Filing date 22 December 2005

Wipo publication date 6 July 2006

Acceptance publication date 17 November 2011

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/071877 Priority application(s): WO2006/071877

17 November 2011 Application Accepted

  Published as AU-B-2005321974

29 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005321978-Multi-party transaction processing system and approach

2005321967-Improved retention and drainage in the manufacture of paper